Case studies

Over the past years, Asc Academics has collaborated on many projects. Below you can find a selection of our noteworthy projects that have made a significant impact not only in the area of health technology but also for patients around the world.

HPV's Economic Burden: Unmasking the benefits of HPV prevention

Asc Academics, in collaboration with MSD and Prof. Postma, anticipated that cost savings associated with the prevention of HPV related cancers and genital warts can result in significant healthcare savings for countries as part of a global report.

Landscape analysis for a breast reconstruction device

Asc Academics performed an analysis on the breast reconstruction landscape.

In-depth market access scan to optimize reimbursement and pricing strategy

Asc Academics performed a market access scan to identify the correct pathway, refine the reimbursement strategy, address data gaps, and optimize pricing, ultimately saving time and ensuring smooth market entry.

Systematic Literature Review for a global oncology drug launch

Asc Academics successfully demonstrated a drug's clinical and economic value for a new breast cancer indication.

Systematic Literature Review on machine learning

Asc Academics performed a systematic literature review (SLR) to identify all relevant articles on machine learning use in health economics and/or market access within the indicated disease context.

In-depth feasibility assessment for performing an indirect treatment comparison

Our team successfully convinced HTA agencies globally that no ITC would be possible.

Stakeholder Report for Market Access Challenges and Solutions in CGT

Asc Academics created a stakeholder report to highlight the views of all stakeholders on the challenges and proposed solutions for improving market access for Cell and Gene Therapy (CGT) in the Netherlands.

Cost-savings models for a COPD and diabetes app

Asc Academics built two cost-savings models (one for COPD and one for diabetes) to calculate the (potential) cost savings of implementing an app for patients to increase their adherence to their prescribed medication regimens.

Global value dossier for a treatment in oncology

Our team synthesized the evidence and has written a full global value dossier for a product in breast cancer.

Adaptation to the Nordic model in rare disease

Our modelling team adapted a model to the Nordics setting.

Burden of illness study in breast cancer

Our team conducted a burden of illness study for a treatment in metastatic breast cancer.

Network meta-analysis for a vaccine

Our team of experts conducted a meta-analysis for a vaccine to compare the safety profiles of the client's vaccine with those already on the market.

Early budget impact model

Our team developed an early budget impact model for a biotech start-up that was in search of investors. A strong value story was needed to show the benefits and associated costs.

Value messaging in breast cancer

Our team has produced a compelling value message for a treatment in metastatic breast cancer.

In-house HEOR support

A short-term outsourcing collaboration with one of our pharmaceutical clients to aid in their urgent need for support.

Survival analysis for a treatment in oncology

Our team conducted a survival analysis for a treatment of breast cancer using immature data.

Literature reviews and economic model for COVID-19

Our team developed an economic model and conducted a literature review to discover niches for the vaccine in COVID-19.

Do you have a question? just asc